Create Alert
Watchlist

Balaxi Pharmaceuticals

₹24.16
-0.95 (3.78%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
25.76
Prev. Close
25.11
Volume
57,435
Total traded value
0.14 Cr
Upper Circuit
30.13
Lower Circuit
20.09

Fundamentals

Market Cap₹139Cr
ROE6.09%
P/E Ratio(TTM)9.55
EPS(TTM)2.63
P/B Ratio0.58
Dividend Yield0.00%
Industry P/E31.72
Book Value43.12
Debt to Equity0.24
Face Value2
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Balaxi Pharma

Balaxi Pharmaceuticals is a globally recognized company enhancing healthcare by providing a wide range of pharmaceuticals in the frontier markets of Latin America and Africa. Its vision is to establish strong product portfolios and channel networks, aiming to expand into 20 frontier markets over the next 5 years. The company's mission is to become a top pharmaceutical player in these markets, focusing on scale, healthy margins, and quality growth in a balanced way. Its diverse portfolio includes a well-balanced mix of generics and branded generics, with products like antibiotics, analgesics, and anti-malaria drugs. As part of its backward integration strategies, it is establishing a pharmaceutical formulation facility in Hyderabad, India to ensure quality and reduce dependency. The company has an impressive track record of 960 product registrations in multiple countries, with another 700 underway to expand its presence.;
Managing DirectorMr. Ashish Maheshwari
Founded1942
NSE SymbolBALAXI

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
65.99%
Retail And Others
30.49%
Foreign Institutions
3.50%
Other Domestic Institutions
0.02%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
JB Chemicals & Pharmaceuticals
NA
(0.00%)
40.46
Emcure Pharmaceuticals
NA
(0.00%)
36.05
Wockhardt
NA
(0.00%)
-434.12
Natco Pharma
NA
(0.00%)
9.72
2026
28
Jan
Result
Upcoming
Release date
2025
11
Nov
Quarterly Result
Release date
5
Aug
Quarterly Result
Release date
30
May
Quarterly & Annual Result
Release date
10
Feb
Quarterly Result
Release date
2024
5
Nov
Quarterly Result
Release date
2
Aug
Quarterly Result
Release date

30
May
Split
Ex date
2:10
Ratio

For each share you hold, you will receive 5 shares with face value of ₹2.0 each
Split Ratio2:10
Ex date30 May ‘24
Record date30 May ‘24
Announcement date28 Feb ‘24
29
May
Result
Release date

28
Feb
Split
Announced
2:10
Ratio

For each share you hold, you will receive 5 shares with face value of ₹2.0 each
Split Ratio2:10
Ex date30 May ‘24
Record date30 May ‘24
Announcement date28 Feb ‘24
Events calendar
View upcoming events in other stocks